3-羟基异吲哚啉-1-酮 | 26486-93-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 中文名称: 3-羟基异吲哚啉-1-酮
• 中文别名: 2,3-二氢-3-羟基-1H-异吲哚-1-酮
• 英文名称: 3-hydroxy-2,3-dihydro-isoindol-1-one
• 英文别名: 3-hydroxyisoindolin-1-one；1H-Isoindol-1-one, 2,3-dihydro-3-hydroxy-；3-hydroxy-2,3-dihydroisoindol-1-one
• CAS: 26486-93-1
• 化学式: C₈H₇NO₂
• 分子量: 149.149
• InChiKey: KAUMDYDNLPQESC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2933790090

反应信息

• 作为反应物：
  描述：

  3-羟基异吲哚啉-1-酮 在 双氧水 作用下， 生成 邻氨甲酰苯甲酸
  参考文献：
  名称：

  Lechat, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1957, vol. 245, p. 326

  摘要：

  DOI：
• 作为产物：
  描述：

  N-丙-2-烯基苯甲酰胺 在 仲丁基锂 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 0.33h， 生成 3-羟基异吲哚啉-1-酮
  参考文献：
  名称：

  Heteroatom-directed metalation. Lithiation of N-propenylbenzamides and N-propenyl-o-toluamides. Novel routes to ortho-substituted primary benzamide derivatives and N-unsubstituted isoquinolin-1(2H)-ones

  摘要：

  Reaction of N-propenylbenzamides 4 and 9, obtained by LDA-induced isomerization of the corresponding N-allylbenzamides 1, 8, and 14, with 2 equiv of sec-butyllithium or tert-butyllithium at low temperature regiospecifically generates the highly reactive N,ortho-dilithiated species (e.g., 5 and 17). These dilithio species react avidly with a wide spectrum of electrophilic reagents, including alkyl halides, giving adducts which on hydrolysis with warm 50% aqueous acetic acid are converted into ortho-substituted primary benzamides in excellent yields. Ortho-lithiation of N-propenylbenzamides is thus formally equivalent to ortho-lithiation of primary benzamides themselves. The utility of this important, previously unknown, synthetic operation is enhanced by the well-known facility with which the primary amide moiety can be transformed into other useful functional groups, as exemplified by the synthesis of 2-methoxy-6-methylbenzoic acid (12) and 2-methoxy-6-methylbenzonitrile (13) from N-propenyl-2-methoxybenzamide (9), N-Propenyl-o-toluamide (7) undergoes regiospecific dilithiation on nitrogen and on the methyl group under conditions analogous to those used for the N-propenylbenzamides. These dilithio species react with DMF or "Weinreb type" amides to give condensation products which cyclize to N-propenylisoquinolin-1(2H)-ones under midly acidic conditions. Removal of the N-propenyl moiety under more strongly acidic conditions provides N-unsubstituted isoquinolin-1(2H)-ones with high overall efficiency. This process is exemplified by the synthesis of isoquinolin-1(2H)-one (23) and its 3-n-butyl congener 26 from N-propenyl-2-methylbenzamide (7).

  DOI：

  10.1021/jo00035a030

文献信息

• [EN] FUSED IMIDAZOLE AND PYRAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY<br/>[FR] DÉRIVÉS D'IMIDAZOLE ET DE PYRAZOLE CONDENSÉS COMME MODULATEURS DE L'ACTIVITÉ DU TNF
  申请人：UCB BIOPHARMA SPRL

  公开号：WO2015086512A1

  公开（公告）日：2015-06-18

  A series of substituted benzimidazole, imidazo[1,2-α]pyridine and pyrazolo[1,5- α]pyridine derivatives, and analogues thereof, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.

  一系列取代苯并咪唑、咪唑并[1,2-α]吡啶和吡唑并[1,5-α]吡啶衍生物及其类似物，作为人类TNFα活性的有效调节剂，因此在治疗和/或预防各种人类疾病方面具有益处，包括自身免疫和炎症性疾病；神经学和神经退行性疾病；疼痛和伤害感知性疾病；心血管疾病；代谢性疾病；眼科疾病；以及肿瘤学疾病。
• One-Pot Double-Annulation Strategy for the Synthesis of Unusual Fused Bis-Heterocycles
  作者：Shukree Abdul-Rashed、Georgios Alachouzos、William W. Brennessel、Alison J. Frontier

  DOI：10.1021/acs.orglett.0c01351

  日期：2020.6.5

  A novel metal-free double-annulation cascade for the construction of unusual fused heterocyclic systems is described. This simple protocol enables the sequential assembly of two rings in one pot from two simple precursors. Acidic conditions promote the condensation and the intramolecular alkynyl Prins reaction of an enyne or arenyne alcohol with a cyclic hemiaminal to form a five-, six-, or seven-membered

  描述了一种新颖的无金属双环环反应级联，用于构造不寻常的稠合杂环系统。这个简单的协议使得两个简单的前体可以在一个罐中顺序组装两个环。酸性条件促进烯炔或芳烃与环状半缩醛的缩合和分子内炔基普林斯反应，形成五元，六元或七元的氧杂环，然后形成七元或八元的氮杂环。在这种转变中，在一个合成操作中形成三个新的键（一个C–O，一个C–C和一个C–N）会迅速产生化学复杂性。该策略是模块化的，相对通用，可访问一系列独特的稠合双环支架。
• Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases
  作者：C. C. Thinnes、A. Tumber、C. Yapp、G. Scozzafava、T. Yeh、M. C. Chan、T. A. Tran、K. Hsu、H. Tarhonskaya、L. J. Walport、S. E. Wilkins、E. D. Martinez、S. Müller、C. W. Pugh、P. J. Ratcliffe、P. E. Brennan、A. Kawamura、C. J. Schofield

  DOI：10.1039/c5cc06095h

  日期：——

  A Betti reaction was used for efficient generation of 2OG oxygenase inhibitors, including for KDM4 demethylases.

  使用Betti反应高效生成2OG氧化酶抑制剂，包括KDM4去甲基酶。
• [EN] REVERSED BIARYL SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS<br/>[FR] ANALOGUES DE BIARYLE SPIROAMINOOXAZOLINE INVERSÉS EN TANT QUE MODULATEURS DU RÉCEPTEUR ALPHA2C ADRÉNERGIQUE
  申请人：SCHERING CORP

  公开号：WO2011041181A1

  公开（公告）日：2011-04-07

  In its many embodiments, the present invention provides a novel class of biaryl spiroaminooxazoline analogues as modulators of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.

  在其多种实施方式中，本发明提供了一种新型的联苯螺环氨氧唑啉类似物，作为α2C肾上腺素受体激动剂的调节剂，以及制备这类化合物的方法，含有一种或多种这类化合物的药物组合物，制备包含一种或多种这类化合物的药物配方的方法，以及使用这类化合物或药物组合物治疗、预防、抑制或改善与α2C肾上腺素受体相关的一种或多种疾病的方法。
• [EN] ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS<br/>[FR] CONJUGUÉS ANTICORPS-MÉDICAMENT (ADC) AVEC DES INHIBITEURS DE NAMPT
  申请人：BAYER PHARMA AG

  公开号：WO2021013693A1

  公开（公告）日：2021-01-28

  Conjugate of a binder having formula (AA) wherein AB stands for a binder, Z' stands for a linker, D stands for an active component which is a NAMPT inhibitor and its use as pharmaceuticals.

  一个具有化学式（AA）的粘合剂的共轭物，其中AB代表粘合剂，Z'代表连接剂，D代表一种活性成分，即NAMPT抑制剂，并且其用作药物。